Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — Februar 2024

Genmab — Februar 2024

Planlagt Fastgjort Låst Flyttet Genmab
1.6k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • SolsenS Offline
    SolsenS Offline
    Solsen
    wrote on sidst redigeret af
    #1478

    Jo døden skal have en årsag. Uanset årsag er det påfaldende at lukke noget ned så hurtigt.

    1 Reply Last reply
    0
    • JørgenVarnæsJ Offline
      JørgenVarnæsJ Offline
      JørgenVarnæs
      wrote on sidst redigeret af
      #1479

      mon de tænker, at covid og den slags er bag os, så det skal der ikke investeres i? Tidligere var der også en slet skjult foragt for RNA terapier i videnskabelige kredse

      1 Reply Last reply
      0
      • SolsenS Offline
        SolsenS Offline
        Solsen
        wrote on sidst redigeret af
        #1480

        https://www.jnj.com/media-center/press-releases/johnson-johnson-opens-state-of-the-art-science-and-technology-campus-in-san-francisco-bay-area “ The R&D focus at the new site spans Janssen’s therapeutic areas and key functions”

        1 Reply Last reply
        0
        • JørgenVarnæsJ Offline
          JørgenVarnæsJ Offline
          JørgenVarnæs
          wrote on sidst redigeret af
          #1481

          generelt fornemmer jeg dog ikke den store excitement for antistoffer. Det lader til at GLP1 molekulerne har taget hele showet i aktiekredse

          1 Reply Last reply
          0
          • JørgenVarnæsJ Offline
            JørgenVarnæsJ Offline
            JørgenVarnæs
            wrote on sidst redigeret af
            #1482

            i onkologi er det noget så usexet som ADC'erne, der har fået comeback

            1 Reply Last reply
            0
            • SolsenS Offline
              SolsenS Offline
              Solsen
              wrote on sidst redigeret af
              #1483

              Ja underligt nok. Moden svinger.

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #1484

                10 stocks with huge cash position vs capitalisation https://twitter.com/aifininsights/status/1762538260805329352

                1 Reply Last reply
                0
                • E Offline
                  E Offline
                  E_L
                  wrote on sidst redigeret af
                  #1485

                  Zai Lab will focus on the following strategic priorities in 2024 to drive innovation in China and beyond:
                  Planned China submissions: [ ]
                  Tisotumab vedotin in second-line+ cervical cancer

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #1486

                    Zai Lab to submit an NDA to the NMPA in second-line+ cervical cancer. https://www.businesswire.com/news/home/20240227802106/en/Zai-Lab-Announces-Full-Year-2023-Financial-Results-and-Recent-Corporate-Updates

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      ProinvestorNEWS
                      wrote on sidst redigeret af
                      #1487

                      Capital Increase in Genmab as a Result of Employee Warrant Exercise https://www.proinvestor.com/investornyt/1124046/capital-increase-in-genmab-as-a-result-of-employee-warrant-exercise

                      1 Reply Last reply
                      0
                      • P Offline
                        P Offline
                        ProinvestorNEWS
                        wrote on sidst redigeret af
                        #1488

                        Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons https://www.proinvestor.com/investornyt/1124047/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons

                        1 Reply Last reply
                        0
                        • V Offline
                          V Offline
                          Vougeot
                          wrote on sidst redigeret af
                          #1489

                          Vi skal på et tidspunkt ned i 1892, så gap'et kan bliver lukket, øv 🙂

                          1 Reply Last reply
                          0
                          • royalR Offline
                            royalR Offline
                            royal
                            wrote on sidst redigeret af
                            #1490

                            Så er det jo easy money. Sælg nu og vent til 1892. 🙂

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Sukkeralf
                              wrote on sidst redigeret af
                              #1491

                              Fedt fedt fedt er vist det eneste der rykker.

                              1 Reply Last reply
                              0
                              • royalR Offline
                                royalR Offline
                                royal
                                wrote on sidst redigeret af
                                #1492

                                På den anden side kan kursen også 2200 inden nogen når at sige Bjarne bruger briller.

                                1 Reply Last reply
                                0
                                • S Offline
                                  S Offline
                                  Sukkeralf
                                  wrote on sidst redigeret af
                                  #1493

                                  Ja når momentum vender skal det nok gå stærkt opad

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #1494

                                    i don't understand why Genmab does not benefit from this weight-loss hype...

                                    1 Reply Last reply
                                    0
                                    • E Offline
                                      E Offline
                                      E_L
                                      wrote on sidst redigeret af
                                      #1495

                                      diarrhea, nausea, vomiting..., I mean it should be clear by now how easy it is to loose weigth just by holding Genmab shares...

                                      1 Reply Last reply
                                      0
                                      • JørgenVarnæsJ Offline
                                        JørgenVarnæsJ Offline
                                        JørgenVarnæs
                                        wrote on sidst redigeret af
                                        #1496

                                        ...except the organization is putting on wheight at an alarming rate

                                        1 Reply Last reply
                                        0
                                        • P Offline
                                          P Offline
                                          ProinvestorNEWS
                                          wrote on sidst redigeret af
                                          #1497

                                          Karakterbogen er landet - Så er det tid til at give karakterer til nogle af de største danske selskaber. Hør blandt andet om Mærsk, ISS, Novo Nordisk, Vestas, Genmab, Rockwool, Carlsberg, Bavarian Nordic og til sidst sluttes der af med en gennemgang af Zealand Pharma https://www.proinvestor.com/boards/119016

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper